Table 4.
Series IV (n = 6): laboratory findings
| After addition of RB before illumination day 1 | Day 2 | Day 4 | Day 6 | Day 8 | |
|---|---|---|---|---|---|
| CD62p, % | |||||
| T-PC | 26.4 ± 16.7 | 27.5 ± 6.2* | 45.9 ± 9.8* | 45.4 ± 10.5 | 61.9 ± 9.6* |
| C-PC | 19.5 ± 8.6 | 21.4 ± 6.7 | 24.2 ± 7.0 | 36.9 ± 16.8 | 26.8 ± 3.9 |
| CD62p + TRAP, % | |||||
| T-PC | 81.9 ± 7.3 | 82.0 ± 6.0* | 72.8 ± 13.4* | 61.1 ± 10.2* | 66.1 ± 7.2 |
| C-PC | 81.1 ± 5.7 | 85.2 ± 4.7 | 80.9 ± 7.6 | 71.1 ± 10.8 | 71.1 ± 3.9 |
| LDH, IU/l | |||||
| T-PC | 136 ± 28 | 132 ± 29* | 144 ± 29 | 153 ± 36* | 164 ± 39 |
| C-PC | 151 ± 26 | 150 ± 26 | 159 ± 25 | 166 ± 28 | 164 ± 33 |
| Glucose, mmol/1012 cells | |||||
| T-PC | 11.9 ± 0.8* | 11.7 ± 1.0* | 7.5 ± 1.7* | 4.4 ± 1.0* | 0.7 ± 1.1* |
| C-PC | 15.2 ± 1.8 | 14.3 ± 1.8 | 12.6 ± 1.1 | 11.2 ± 1.7 | 9.0 ± 1.6 |
| Lactate, mmol/1012 cells | |||||
| T-PC | 4.5 ± 0.8 | 7.9 ± 1.0* | 15.6 ± 3.7* | 21.8 ± 1.7* | 30.0 ± 2.3* |
| C-PC | 4.3 ± 0.6 | 5.8 ± 0.9 | 10.6 ± 2.4 | 13.9 ± 2.0 | 17.5 ± 2.4 |
*
p < 0.05; T-PC (PRT-treated unit) versus C-PC (untreated control unit).